The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group
PH Stone,
JE Muller,
T Hartwell,
BJ York,
JD Rutherford,
CB Parker,
ZG Turi,
HW Strauss,
JT Willerson,
T Robertson,
et al.
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Patients with diabetes mellitus experience a more adverse outcome after acute myocardial infarction compared with nondiabetic patients, although the mechanisms responsible for these findings are not clear. From the Multicenter Investigation of the Limitation of Infarct Size (MILIS) study, the course of acute infarction in 85 diabetic patients was compared with that in 415 nondiabetic patients, all of whom had serial assessments of left ventricular function. The diabetic patients experienced a more complicated in-hospital and postdischarge course than did the nondiabetic patients, including a higher incidence of postinfarction angina, infarct extension, heart failure and death, despite the development of a smaller infarct size and similar levels of left ventricular ejection fraction. Although diabetic patients had a worse profile of cardiovascular risk factors at the time of the index infarction, the increased incidence of adverse outcomes among them persisted despite adjustment for these baseline imbalances. Diabetic women had a poor baseline risk profile compared with the other groups categorized by gender and diabetic status, and experienced an almost twofold increase in cardiac mortality despite development of the smallest infarct size during the index event. The duration of diabetes and the use of insulin at the time of the index infarction were associated with a better in-hospital mortality rate, but the duration of diabetes did not exert a major influence on the outcome of the diabetic patients. The factors responsible for the increased incidence of adverse outcomes among diabetic patients may be related to an acceleration of the atherosclerotic process, diastolic left ventricular dysfunction associated with diabetic cardiomyopathy or other unidentified unfavorable processes.
This article has been cited by other articles:
|
|
|
|
 
C. Bianchi, R. Miccoli, G. Daniele, G. Penno, and S. Del Prato
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Diabetes Care,
November 1, 2009;
32(suppl_2):
S342 - S348.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Matsushima, S. Kinugawa, T. Yokota, N. Inoue, Y. Ohta, S. Hamaguchi, and H. Tsutsui
Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes
Am J Physiol Heart Circ Physiol,
July 1, 2009;
297(1):
H409 - H416.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Lieb, V. Xanthakis, L. M. Sullivan, J. Aragam, M. J. Pencina, M. G. Larson, E. J. Benjamin, and R. S. Vasan
Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study
Circulation,
June 23, 2009;
119(24):
3085 - 3092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Hofsten, B. B. Logstrup, J. E. Moller, P. A. Pellikka, and K. Egstrup
Abnormal glucose metabolism in acute myocardial infarction influence on left ventricular function and prognosis.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
592 - 599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Nicholls, E. M. Tuzcu, S. Kalidindi, K. Wolski, K.-W. Moon, I. Sipahi, P. Schoenhagen, and S. E. Nissen
Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
255 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kinnaird, E. Stabile, S. Zbinden, M.-S. Burnett, and S. E. Epstein
Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions
Cardiovasc Res,
May 1, 2008;
78(2):
257 - 264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Navarro, C. Mora, M. Gomez, M. Muros, C. Lopez-Aguilar, and J. Garcia
Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-{alpha} and interleukin-6 in type 2 diabetic patients
Nephrol. Dial. Transplant.,
March 1, 2008;
23(3):
919 - 926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Lekli, G. Szabo, B. Juhasz, S. Das, M. Das, E. Varga, L. Szendrei, R. Gesztelyi, J. Varadi, I. Bak, et al.
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H859 - H866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B.-O. Kim, S. Verma, R. D. Weisel, S. Fazel, Z.-Q. Jia, T. Mizuno, and R.-K. Li
Preservation of heart function in diabetic rats by the combined effects of muscle cell implantation and insulin therapy
Eur J Heart Fail,
January 1, 2008;
10(1):
14 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J.J. Ijsselmuiden, C. G. Schalkwijk, J. G.F. Bronzwaer, M. Diamant, et al.
Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension
Circulation,
January 1, 2008;
117(1):
43 - 51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. van Lunteren and M. Moyer
Oxidoreductase, morphogenesis, extracellular matrix, and calcium ion-binding gene expression in streptozotocin-induced diabetic rat heart
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E759 - E768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Chandler, E. E. Morgan, T. A. McElfresh, T. A. Kung, J. H. Rennison, B. D. Hoit, and M. E. Young
Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1609 - H1616.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pelletier and L. Coderre
Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1325 - E1332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C. N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi
Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts
Am J Physiol Endocrinol Metab,
April 1, 2007;
292(4):
E1030 - E1040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Schofield, G. Libby, G. M. Brennan, R. R. MacAlpine, A. D. Morris, G. P. Leese, and for the DARTS/MEMO Collaboration
Mortality and Hospitalization in Patients After Amputation: A comparison between patients with and without diabetes
Diabetes Care,
October 1, 2006;
29(10):
2252 - 2256.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol,
October 1, 2006;
291(4):
H1489 - H1506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sulfi and A. D Timmis
Review: Heart failure complicating acute myocardial infarction in patients with diabetes: pathophysiology and management strategies
The British Journal of Diabetes & Vascular Disease,
September 1, 2006;
6(5):
191 - 196.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Chaowalit, A. L. Arruda, R. B. McCully, K. R. Bailey, and P. A. Pellikka
Dobutamine Stress Echocardiography in Patients With Diabetes Mellitus: Enhanced Prognostic Prediction Using a Simple Risk Score
J. Am. Coll. Cardiol.,
March 7, 2006;
47(5):
1029 - 1036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum
Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes
Clin. J. Am. Soc. Nephrol.,
March 1, 2006;
1(2):
193 - 208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Saha and A. D Timmis
Review: Diabetic autonomic dysfunction: adverse effects on presentation, management and outcomes of acute coronary syndromes
The British Journal of Diabetes & Vascular Disease,
September 1, 2005;
5(5):
260 - 264.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Verges, M. Zeller, J. Desgres, G. Dentan, Y. Laurent, L. Janin-Manificat, I. L'Huillier, G. Rioufol, J.-C. Beer, H. Makki, et al.
High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock
Eur. Heart J.,
September 1, 2005;
26(17):
1734 - 1741.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Suleiman, D. Aronson, R. Asleh, M. R. Kapeliovich, A. Roguin, S. R. Meisel, M. Shochat, A. Sulieman, S. A. Reisner, W. Markiewicz, et al.
Haptoglobin Polymorphism Predicts 30-Day Mortality and Heart Failure in Patients With Diabetes and Acute Myocardial Infarction
Diabetes,
September 1, 2005;
54(9):
2802 - 2806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Figueras, C Pena, and J Soler-Soler
Thirty day prognosis of patients with acute pulmonary oedema complicating acute coronary syndromes
Heart,
July 1, 2005;
91(7):
889 - 893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Thrainsdottir, T. Aspelund, G. Thorgeirsson, V. Gudnason, T. Hardarson, K. Malmberg, G. Sigurdsson, and L. Ryden
The Association Between Glucose Abnormalities and Heart Failure in the Population-Based Reykjavik Study
Diabetes Care,
March 1, 2005;
28(3):
612 - 616.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B S Rana, P O Lim, A A O Naas, S A Ogston, R W Newton, R T Jung, A D Morris, and A D Struthers
QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests
Heart,
January 1, 2005;
91(1):
44 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. V. Donthi, G. Ye, C. Wu, D. A. McClain, A. J. Lange, and P. N. Epstein
Cardiac Expression of Kinase-deficient 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Inhibits Glycolysis, Promotes Hypertrophy, Impairs Myocyte Function, and Reduces Insulin Sensitivity
J. Biol. Chem.,
November 12, 2004;
279(46):
48085 - 48090.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Murcia, C. H. Hennekens, G. A. Lamas, M. Jimenez-Navarro, J. L. Rouleau, G. C. Flaker, S. Goldman, H. Skali, E. Braunwald, and M. A. Pfeffer
Impact of Diabetes on Mortality in Patients With Myocardial Infarction and Left Ventricular Dysfunction
Arch Intern Med,
November 8, 2004;
164(20):
2273 - 2279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Carrabba, R. Valenti, G. Parodi, G. M. Santoro, and D. Antoniucci
Left Ventricular Remodeling and Heart Failure in Diabetic Patients Treated With Primary Angioplasty for Acute Myocardial Infarction
Circulation,
October 5, 2004;
110(14):
1974 - 1979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Aguilar, S. D. Solomon, L. Kober, J.-L. Rouleau, H. Skali, J. J.V. McMurray, G. S. Francis, M. Henis, C. M. O'Connor, R. Diaz, et al.
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Circulation,
September 21, 2004;
110(12):
1572 - 1578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Bibbins-Domingo, F. Lin, E. Vittinghoff, E. Barrett-Connor, S. B. Hulley, D. Grady, and M. G. Shlipak
Predictors of Heart Failure Among Women With Coronary Disease
Circulation,
September 14, 2004;
110(11):
1424 - 1430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Arch Intern Med,
September 13, 2004;
164(16):
1737 - 1748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Marfella, K. Esposito, F. Nappo, M. Siniscalchi, F. C. Sasso, M. Portoghese, M. Pia Di Marino, A. Baldi, S. Cuzzocrea, C. Di Filippo, et al.
Expression of Angiogenic Factors During Acute Coronary Syndromes in Human Type 2 Diabetes
Diabetes,
September 1, 2004;
53(9):
2383 - 2391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Raggi, L. J. Shaw, D. S. Berman, and T. Q. Callister
Prognostic value of coronary artery calcium screening in subjects with and without diabetes
J. Am. Coll. Cardiol.,
May 5, 2004;
43(9):
1663 - 1669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Thrainsdottir, K. Malmberg, A. Olsson, M. Gutniak, and L. Ryden
Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure
Diabetes and Vascular Disease Research,
May 1, 2004;
1(1):
40 - 43.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen, and DIAMOND Study Group
Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
J. Am. Coll. Cardiol.,
March 3, 2004;
43(5):
771 - 777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P L Sanchez, J L Morinigo, P Pabon, F Martin, I Piedra, I F Palacios, and C Martin-Luengo
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome
Heart,
March 1, 2004;
90(3):
264 - 269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Lee, A. R. Folsom, J. S. Pankow, F. L. Brancati, and For the Atherosclerosis Risk in Communities (ARIC)
Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction
Circulation,
February 24, 2004;
109(7):
855 - 860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S.H. Bell
Heart Failure: The frequent, forgotten, and often fatal complication of diabetes
Diabetes Care,
August 1, 2003;
26(8):
2433 - 2441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Shiomi, H. Tsutsui, M. Ikeuchi, H. Matsusaka, S. Hayashidani, N. Suematsu, J. Wen, T. Kubota, and A. Takeshita
Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction
J. Am. Coll. Cardiol.,
July 2, 2003;
42(1):
165 - 172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Borghi, S. Bacchelli, D. D. Esposti, and E. Ambrosioni
Effects of the Early ACE Inhibition in Diabetic Nonthrombolyzed Patients With Anterior Acute Myocardial Infarction
Diabetes Care,
June 1, 2003;
26(6):
1862 - 1868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Alter, Y. Khaykin, P. C. Austin, J. V. Tu, and J. E. Hux
Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat?
Diabetes Care,
May 1, 2003;
26(5):
1427 - 1434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Foo, J Cooper, A Deaner, C Knight, A Suliman, K Ranjadayalan, and A D Timmis
A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes
Heart,
May 1, 2003;
89(5):
512 - 516.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. N. Finck, X. Han, M. Courtois, F. Aimond, J. M. Nerbonne, A. Kovacs, R. W. Gross, and D. P. Kelly
A critical role for PPARalpha -mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content
PNAS,
February 4, 2003;
100(3):
1226 - 1231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-M. Lee and T.-F. Chou
Impairment of Myocardial Protection in Type 2 Diabetic Patients
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
531 - 537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Calafiore, M. Di Mauro, G. Di Giammarco, M. Contini, G. Vitolla, A. Lorena Iaco, C. Canosa, and S. D'Alessandro
Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease
J. Thorac. Cardiovasc. Surg.,
January 1, 2003;
125(1):
144 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chyun, V. Vaccarino, J. Murillo, L. H. Young, and H. M. Krumholz
Cardiac Outcomes After Myocardial Infarction in Elderly Patients With Diabetes Mellitus
Am. J. Crit. Care.,
November 1, 2002;
11(6):
504 - 519.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, E. C. Vourvouri, F. B. Sozzi, R. Valkema, J. R.T.C. Roelandt, and D. Poldermans
Prognostic Value of Dobutamine-Atropine Stress Myocardial Perfusion Imaging in Patients With Diabetes
Diabetes Care,
September 1, 2002;
25(9):
1637 - 1643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Egede and D. Zheng
Modifiable Cardiovascular Risk Factors in Adults With Diabetes: Prevalence and Missed Opportunities for Physician Counseling
Arch Intern Med,
February 25, 2002;
162(4):
427 - 433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z S Kyriakides, S Psychari, N Chrysomallis, M Georgiadis, E Sbarouni, and D T Kremastinos
Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty
Heart,
January 1, 2002;
87(1):
61 - 66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. LaRosa
Prevention and Treatment of Coronary Heart Disease: Who Benefits?
Circulation,
October 2, 2001;
104(14):
1688 - 1692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ghosh, N. B. Standen, and M. Galinanes
Failure to precondition pathological human myocardium
J. Am. Coll. Cardiol.,
March 1, 2001;
37(3):
711 - 718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Gustafsson and P. Hildebrandt
Early Failure of the Diabetic Heart
Diabetes Care,
January 1, 2001;
24(1):
3 - 4.
[Full Text]
|
|
|
|
|
|
|
T. Melchior, C. Rask-Madsen, C. Torp-Pedersen, P. Hildebrandt, L. Kober, and G. Jensen
The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction: a 15-year follow-up study
Eur J Heart Fail,
January 1, 2001;
3(1):
83 - 90.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I Gustafsson, P Hildebrandt, M Seibaek, T Melchior, C Torp-Pedersen, L Kober, and P Kaiser-Nielsen
Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen
Eur. Heart J.,
December 1, 2000;
21(23):
1937 - 1943.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Malmberg, S. Yusuf, H. C. Gerstein, J. Brown, F. Zhao, D. Hunt, L. Piegas, J. Calvin, M. Keltai, A. Budaj, et al.
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non-Q-Wave Myocardial Infarction : Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry
Circulation,
August 29, 2000;
102(9):
1014 - 1019.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Norhammar and K. Malmberg
Heart failure and glucose abnormalities: an increasing combination with poor functional capacity and outcome
Eur. Heart J.,
August 2, 2000;
21(16):
1293 - 1294.
[PDF]
|
|
|
|
|
|
|
S Kennon, K Barakat, A Suliman, P K MacCallum, K Ranjadayalan, P Wilkinson, and A D Timmis
Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction
Heart,
July 1, 2000;
84(1):
41 - 45.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Mehta, T. J. Ruane, P. A. McCargar, K. A. Eagle, and E. J. Stalhandske
The Treatment of Elderly Diabetic Patients With Acute Myocardial Infarction: Insight From Michigan's Cooperative Cardiovascular Project
Arch Intern Med,
May 8, 2000;
160(9):
1301 - 1306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B Almbrand, M Johannesson, B Sjostrand, K Malmberg, and L Ryden
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus. Results from the DIGAMI study
Eur. Heart J.,
May 1, 2000;
21(9):
733 - 739.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Hasdai, C. B. Granger, S. S. Srivatsa, D. A. Criger, S. G. Ellis, R. M. Califf, E. J. Topol, and D. R. Holmes Jr.
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1502 - 1512.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-H. Mak and E. J. Topol
Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
J. Am. Coll. Cardiol.,
March 1, 2000;
35(3):
563 - 568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. I. Joffe, K. E. Travers, C. L. Perreault-Micale, T. Hampton, S. E. Katz, J. P. Morgan, and P. S. Douglas
Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat: Noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway
J. Am. Coll. Cardiol.,
December 1, 1999;
34(7):
2111 - 2119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
1262 - 1347.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, and V. Fuster
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
1348 - 1359.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Grundy, R. Pasternak, P. Greenland, S. Smith Jr, and V. Fuster
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations : A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Circulation,
September 28, 1999;
100(13):
1481 - 1492.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Grundy, I. J. Benjamin, G. L. Burke, A. Chait, R. H. Eckel, B. V. Howard, W. Mitch, S. C. Smith Jr, and J. R. Sowers
Diabetes and Cardiovascular Disease : A Statement for Healthcare Professionals From the American Heart Association
Circulation,
September 7, 1999;
100(10):
1134 - 1146.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Grundy
Primary Prevention of Coronary Heart Disease : Integrating Risk Assessment With Intervention
Circulation,
August 31, 1999;
100(9):
988 - 998.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gottlieb, V. Boyko, D. Harpaz, H. Hod, M. Cohen, L. Mandelzweig, Z. Khoury, S. Stern, S. Behar, and for the Israeli Thrombolytic Survey Group
Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction
J. Am. Coll. Cardiol.,
July 1, 1999;
34(1):
70 - 82.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Gustafsson, C. Torp-Pedersen, L. Kober, F. Gustafsson, P. Hildebrandt, and on behalf of the Trace Study Group
Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction
J. Am. Coll. Cardiol.,
July 1, 1999;
34(1):
83 - 89.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abaci, S. Kahraman, N. K. Eryol, H. Arinc, and A. Ergin
Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels
Circulation,
May 4, 1999;
99(17):
2239 - 2242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. S. Aronow and C. Ahn
Incidence of Heart Failure in 2,737 Older Persons With and Without Diabetes Mellitus
Chest,
March 1, 1999;
115(3):
867 - 868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kennon, A. Suliman, P. K. MacCallum, K. Ranjadayalan, P. Wilkinson, and A. D. Timmis
Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes
J. Am. Coll. Cardiol.,
December 1, 1998;
32(7):
2018 - 2022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Zuanetti, R. Latini, A. P. Maggioni, M. Franzosi, L. Santoro, G. Tognoni, and G. 3 Investigators
Effect of the ACE Inhibitor Lisinopril on Mortality in Diabetic Patients With Acute Myocardial Infarction : Data From the GISSI-3 Study
Circulation,
December 16, 1997;
96(12):
4239 - 4245.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. W SAYER and A. D TIMMIS
Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary?
Heart,
December 1, 1997;
78(6):
525 - 526.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. B. Investigators
Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI)
Circulation,
September 16, 1997;
96(6):
1761 - 1769.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Tosaki and D. K. Das
Extracellular Mg++ Manipulation Prevents the Proarrhythmic Activity of Cromakalim in Ischemic/Reperfused Diabetic Hearts
J. Pharmacol. Exp. Ther.,
July 1, 1997;
282(1):
309 - 317.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. Malmberg
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
BMJ,
May 24, 1997;
314(7093):
1512 - 1512.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Goldberg, M. P. Savage, and D. L. Fischman
The Interventional Cardiologist and the Diabetic Patient: Have We Pushed the Envelope Too Far or Not Far Enough?
Circulation,
October 15, 1996;
94(8):
1804 - 1806.
[Full Text]
|
|
|
|
|
|
|
P. Wilkinson, J. Sayer, K. Laji, C. Grundy, B. Marchant, P. Kopelman, and A. D Timmis
Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study
BMJ,
May 25, 1996;
312(7042):
1330 - 1333.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. Levy, M. G. Larson, R. S. Vasan, W. B. Kannel, and K. K. L. Ho
The Progression From Hypertension to Congestive Heart Failure
JAMA,
May 22, 1996;
275(20):
1557 - 1562.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. H. Stone, B. Thompson, H. V. Anderson, M. W. Kronenberg, R. S. Gibson, W. J. Rogers, D. J. Diver, P. Theroux, J. W. Warnica, J. B. Nasmith, et al.
Influence of Race, Sex, and Age on Management of Unstable Angina and Non--Q-Wave Myocardial Infarction: The TIMI III Registry
JAMA,
April 10, 1996;
275(14):
1104 - 1112.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. S. Vasan, E. J. Benjamin, and D. Levy
Congestive Heart Failure With Normal Left Ventricular Systolic Function: Clinical Approaches to the Diagnosis and Treatment of Diastolic Heart Failure
Arch Intern Med,
January 22, 1996;
156(2):
146 - 157.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Bueno, M. T. Vidan, A. Almazan, J. L. Lopez-Sendon, and J. L. Delcan
Influence of Sex on the Short-term Outcome of Elderly Patients With a First Acute Myocardial Infarction
Circulation,
September 1, 1995;
92(5):
1133 - 1140.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. W. M. Muller and E. J. Topol
Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy
Ann Intern Med,
December 15, 1990;
113(12):
949 - 960.
[Abstract]
[PDF]
|
|
|
|
